Aptargroup Inc (ATR)
適正価値ファンダメンタル
66
株価
$120.22
時価総額
$7.91B
パート1 · 企業の価値
概要
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 2026年9月18日 with claude-haiku-4-5 — shared with all users
It supplies the elastomeric stoppers, seals and injection delivery systems that compete head-on with Aptar Pharma's injectables business for the same drug makers.
Through Silgan Dispensing Systems it makes the same pumps, trigger sprayers and dispensing closures Aptar sells to beauty, home care and food and beverage brands.
This French maker of nasal sprays, preservative-free eyedroppers and inhalers bids for the same drug-delivery device contracts with pharmaceutical companies as Aptar Pharma.
The German group sells inhalers, pen injectors and primary pharmaceutical packaging, and also cosmetics packaging, to the same pharma and beauty customers Aptar serves in Europe and the United States.
After absorbing Berry Global in April 2025 it is a large supplier of closures, dispensing components and healthcare packaging to the consumer and pharmaceutical brands Aptar depends on.
The privately held German closure specialist competes with Aptar's Food + Beverage segment on dispensing and non-dispensing plastic caps for drinks, edible oils and household liquids.
貸借対照表と流動性
売上高
$3.93B
直近12か月（2026/6/30まで）
純利益
$363M
直近12か月（2026/6/30まで）
フリーキャッシュフロー
$300M
自己資本合計
$2.67B
負債合計
$2.57B
流動比率
1.61
利払い倍率
7.52
負債/EBITDA
1.79
一株当たり利益（EPS）
売上高と純利益
フリーキャッシュフロー
収益内訳
財務推移表
利益率の推移
負債の推移
負債の重さ
成長率グリッド
成長率 — 売上高
適正価値の推定
適正価値
$154.38
現在株価
$120.22
安全マージン
+22.1%
適正価値レンジ
$116.80 - $191.96
使用した評価手法間のばらつきであり、統計的に較正された信頼区間ではありません。
推定方法
バリュエーション指標
P/E レシオ
21.91
ROE
14.7%
P/B レシオ
2.93
P/FCF
24.82
粗利益率
-
ROIC
9.4%
収益性レーダー
価値創造（経済的モート）
ROIC
9.4%
WACC
7.2%
ROIC − WACC
+2.2 pp
ROICが資本コストを上回っています。企業は株主のために価値を創出しています。
ファンダメンタル分析基準
合格（21）
- EPS shows upward trend
- EPS CAGR 6.02%
- Price CAGR 5.45%
- ROIC 9.4%
- P/FCF 24.82
- P/B Ratio 2.93
- Debt/Equity ratio
- Operating Margin 12.1%
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 13.6%
- Revenue Growth 5Y 5.2%
- Analyst Consensus 83% Buy
- Earnings Surprise avg 4.0%
- PEG Ratio 1.66
- Earnings Quality (OCF/NI) 1.61
- Share Dilution -1.5%
- Piotroski F-Score 5/9
不合格（5）
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Net Margin Trend 9.2% vs 10.8%
データなし（2）
- Gross Margin NaN%
- Dividend Payout NaN%
Piotroski F-スコア
まちまちのシグナル：一部の領域に注意が必要
利益の質
高品質：利益はキャッシュに裏付けられている
株式希薄化
株式を買い戻している。株主に友好的
機関投資家の保有
この企業について機関投資家の報告はありません。
ガバナンス
経営陣
| 氏名 | 役職 | 年齢 |
|---|---|---|
| Mr. Gael Touya | CEO, President & Director | 55 |
| Ms. Vanessa Kanu | Executive VP & CFO | 47 |
| Mr. Stephan B. Tanda | Director & Advisor | 60 |
| Mr. Marc Prieur | President of Aptar Beauty | 59 |
| Ms. Xiangwei Gong | Executive VP of Strategic Group Development & President of Aptar Asia | 55 |
| Mr. Hedi Tlili | President of Aptar Closures | 50 |
| Mr. Aditya J. Gandhi | VP, Principal Accounting Officer & Chief Accounting Officer | 45 |
| Ms. Mary Skafidas | Senior Vice President of Investor Relations & Communications | - |
| Ms. Irene Hudson | Executive VP, Chief Legal Officer & Corporate Secretary | 48 |
| Ms. Shiela Pallerne Vinczeller | Chief Human Resources Officer | 61 |
監査リスク
1
取締役会リスク
1
報酬リスク
2
株主権利リスク
5
パート2 · 株価と買い時
この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容：テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。
業績推移
via SEC EDGAR
Latest News
Recent headlines for ATR, sourced from Markets Gazette.
- 28d agoPOSITIVEATR (JV Leonardo-Airbus), maxi ordine da 1 miliardo di dollari dall'indiana FLY91
Indian regional airline FLY91 has placed a landmark order for 40 ATR 72-600 aircraft, valued at approximately $1 billion. This significant deal represents the largest order for ATR globally from a single airline. The ATR 72-600 is a turboprop regional airliner, and this order underscores FLY91's commitment to expanding its regional network. For investors in Leonardo (a partner in the ATR joint venture), this order signals strong demand for regional aircraft and a positive outlook for the turboprop market, potentially boosting future revenues and profitability.
- 2/28/2026POSITIVERiver Road Loads Up on ATR With 917,000 Shares in New Position
River Road, a prominent investment manager, has announced the establishment of a new significant position in AptarGroup Inc., acquiring 917,000 shares. AptarGroup is a global provider of proprietary dispensing and sealing solutions for the healthcare, beauty, and consumer markets. This strategic move by River Road signals strong confidence in AptarGroup's future prospects, suggesting the company may be undervalued or poised for significant growth. Investors might interpret this as a bullish signal, indicating potential increased interest and demand for ATR shares, given its robust global market positioning.
via Markets Gazette